// App-Quantinova.ai

: Use of Eculizumab for the Treatment of Hyperhaemolysis in Pregnancy in Sickle Cell Disease: A Case Report

Researchers

Presenter

  • Laura Chebet Kirui

Principal Investigators

  • Marie Scully

  • Norma Mcqueen

  • John Porter

  • Perla Eleftheriou

Medical Centers

  • Haematology, University college London hospital, london, United Kingdom

  • Department of Medical Oncology, University College London Hospital, London, United Kingdom

  • Department of Urology, King's College Hospital NHS Foundation Trust, London, United Kingdom

  • Kings College London, London, United Kingdom

  • Professor of Haematology and Consultant Haematologist, University College London; University College London Hospitals, London, United Kingdom

  • University College London Hospitals NHS Trust, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Sickle cell anemia

Biomarkers

  • Dopamine transporter

Drug/Treatment

  • Methylprednisolone

  • Eculizumab

  • Rituximab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved